We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IOBT market cap is 54.87M. The company's latest EPS is USD -1.3066 and P/E is -0.64.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.85M | -23.48M | -28.18M | -20.2M | -21.53M |
| Net Income | -21.18M | -21.68M | -26.18M | -19.46M | -20.69M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -41.23M | -71.42M | -91.44M |
| Net Income | -74.99M | -71.46M | -86.08M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 117.56M | 172.55M | 150.72M | 128.16M | 111.47M |
| Total Liabilities | 13.04M | 14.96M | 17.56M | 12.69M | 15.2M |
| Total Equity | 104.52M | 157.59M | 133.16M | 115.47M | 96.27M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 222.29M | 151.81M | 150.72M |
| Total Liabilities | 10.36M | 12.95M | 17.56M |
| Total Equity | 211.92M | 138.85M | 133.16M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -32.95M | -48.94M | -71.74M | -24.93M | -41.91M |
| Investing | -187k | -211k | -323k | -11k | -23k |
| Financing | N/A | 71.87M | 71.86M | N/A | N/A |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.65M | -59.73M | -71.74M |
| Investing | -153k | -690k | -323k |
| Financing | 252.95M | N/A | 71.86M |
| Market Cap | 54.87M |
| Price to Earnings Ratio | -0.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.38 |
| Price to Book Ratio | 0.41 |
| Dividend Yield | - |
| Shares Outstanding | 65.88M |
| Average Volume (1 week) | 430.77k |
| Average Volume (1 Month) | 760.04k |
| 52 Week Change | -31.73% |
| 52 Week High | 2.098 |
| 52 Week Low | 0.66 |
| Spread (Intraday) | 0.07 (7.46%) |
| Company Name | IO Biotech Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.iobiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
